Avelos Therapeutics

Avelos Therapeutics

Develops next-generation targeted oncology medicines with high unmet need, to a wider range of possibilities with present and future applications.

HQ location
Seoul, South Korea
Launch date
Employees
Enterprise value
$50—75m
Company register number
4388702223
Authorizing premium user...